This volume presents results from the tenth anniversary meeting of the British Association for Psychopharmacology. It differs from previous BAP monographs in being a general review of the entire discipline, describing extensive recent progress, and identifying areas where work remains to be done. The papers focus on five major areas: depression and antidepressants, anxiolytics, cognitive disorders (particularly Alzheimer's disease), schizophrenia,...